SUMMARY The adult non-neuropathic form of Gaucher's disease has been identified in 32 patients in 25 Ashkenazi Jewish kindreds in South Africa. The minimum prevalence in this population is 1 in 5000, with a gene frequency of 0 .014 and a carrier rate of 1 in 36. On correction for bias resulting from possible under-ascertainment, these minimum figures become 1 in 4000, 0.0166, and 1 in 30, respectively. Confirmation of autosomal recessive inheritance was obtained by segregation analysis by the 'a priori' and 'simple sib' methods.
The Ashkenazim of South Africa have their origins in Lithuania and it is evident that the high gene frequency in South Africa is a reflection of the genetic constitution of the immigrant population. The localisation of the' Gaucher gene to Lithuania represents a further step in the determination of the early geographic distribution of the genetic disorders of the Jewish race.
The adult chronic or non-neuropathic form of Gaucher's disease is an autosomal recessive disorder in which activity of the enzyme 3-glucosidase is defective. The condition runs a fluctuant but progressive course and the main clinical problems are splenomegaly, dyshaemopoeisis, osteitis, and collapse of weight-bearing joints (Matoth and Fried, 1965) .
This type of Gaucher's disease is relatively common in the Ashkenazi Jewish population of South Africa (Beighton and Sacks, 1974 The juvenile form is characterised by progressive dementia, cerebellar ataxia, and extrapyramidal dysfunction. The majority of patients have been reported from Sweden.
The adult chronic or non-neuropathic type, which forms the subject of this paper, usually presents in early adulthood. Lack of involvement of the central nervous system and a predominance in people of Ashkenazi Jewish stock are the main distinguishing features (Fried et al., 1963 Town. 3-glucosidase activity was determined in the white cells of the respondents and their sibs by the method of Beutler and Kuhl (1970) . Before these special studies, the diagnosis had already been confirmed in the majority of patients by demonstration of the typical foamy Gaucher cells in bone marrow biopsy specimens.
Results
Thirty-two Ashkenazi Jewish patients in 25 kindreds were ascertained. Of these, 24 in 21 families were examined and investigated, while firm medical evidence permitted a positive diagnosis in 4 sibs of these subjects who were abroad or deceased. Medical data were also available concerning 4 other affected Jews in South Africa, who were not available for examination in the survey.
PREVALENCE
On a basis of the 24 living patients with Gaucher's disease in a total Jewish population of 120 000, the minimum prevalence of the disorder in this group is about 1:5000. This figure rises to approximately 1:4000 if the 4 patients who were not examined are included in the calculation.
GENE FREQUENCY
Taking the figures of 24 homozygotes in a population of 120 000, with a prevalence of 1:5000, the gene frequency (q) is 0-014. Therefore, the frequency of heterozygotes (2pq) is 0-028 (1/36) and the number of heterozygotes in the population of 120000 is 3346.
If these figures are recalculated with the inclusion of the 4 patients who were not examined, together with an estimate of existing undiagnosed cases, based upon average age of presentation, birth rate, and population size, the minimum prevalence becomes 1:4000, with a gene frequency of 0-0166, and a carrier rate of 1 in 30 or 0-332.
GEOGRAPHIC ORIGINS
Information concerning the geographic origins of immigrant progenitors was available from 20 kindreds. In 13, both paternal and maternal families had lived in Greater Lithuania during the 19th century. In 6, only one side of the kindred came from this area, the others originating in Russia (4), Holland (1), and Czechoslovakia (1). In one family, both parents had emigrated to South Africa from Germany and had no known ancestral connections with Lithuania. The area of origin of the Gaucher's disease gene in Europe is shown in Fig. 1 , in relationship to the distribution of other genetic disorders which reach their highest prevalence in the Ashkenazim, as determined by Meals (1970) . PEDIGREE DATA Abbreviated pedigree data concerning the 21 kindreds are shown in Fig. 2 . There were 15 male and 13 female patients.
There was no generation to generation transmission. Known consanguinity was present in one kindred.
The results of segregation analysis on 21 informative kindreds by the 'a priori' or Apert method were in accordance with autosomal recessive inheritance (21 sibships, 71 sibs, 28 affected, 28 98 expected, SE 2 69). Analysis by the simple sib method, after deletion of the proband, gave 7 observed, 12.5 expected, with a variance of 6 (limits 6 5 to 18 5), thus confirming the autosomal recessive mode of inheritance. Fig. 1 Initial European localisation of Gaucher's disease and other autosomal recessive disorders of the Ashkenazi Jews (Meals, 1970) . Though activity of the enzyme P-glucosidase is defective in affected subjects in all populations the manifestations of the disease develop earlier and are more severe in the Afrikaners. At a fundamental level, it is not known whether the abnormal genes in the different communities are identical, allelic, or situated at different loci.
The high frequency of the Gaucher disease gene in the Jewish population of South Africa is of potential importance from the point of view of screening and prevention. However, laboratory procedures for detection of heterozygotes are complex, and at present population screening is not feasible.
From the clinical point of view, the high prevalence of Gaucher's disease in this community is important in terms ofdifferential diagnosis. Indeed, unexplained splenomegaly or orthopaedic problems in a young adult of South African Jewish stock immediately raise the possibility of Gaucher's disease .
